Antibacterial chemokines - Actors in both innate and adaptive immunity

Contributions to Microbiology

Volumn 15, Issue , 2008, Pages 101-117

  Eliasson, M ^a   Egesten, A ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHEMOKINE; COMPLEMENT; PEPTIDE; PROTEIN;

ANIMAL; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MULTIGENE FAMILY; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; CHEMOKINES; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, NATURAL; MULTIGENE FAMILY; PEPTIDES; PROTEINS;

EID: 49449114876     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000136317     Document Type: Review

References (63)

1. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ: Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1). J Immunol 1987;139:788-793.
2. Walz A, Peveri P, Aschauer H, Baggiolini M: Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 1987;149:755-761.
3. Schöder JM, Mrowietz U, Morita E, Christophers E: Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987;139:3474-3483.
4. Baggiolini M: Chemokines in pathology and medicine. J Intern Med 2001;250:91-104.
5. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM: Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 2001;167:623-627.
6. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ: Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003;74:448-455.
7. Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, Shiba F, Shiota M, Katou F, Saito T, Yoshie O: CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 2003;170:1452-1461.
8. Magor BG, Magor KE: Evolution of effectors and receptors of innate immunity. Dev Comp Immunol 2001;25:651-682.
9. Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD: Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J Immunol 2006;177:6991-6998.
10. Proudfoot AE: The biological relevance of chemokine-proteoglycan interactions. Biochem Soc Trans 2006;34:422-426.
11. Viola A, Luster AD: Chemokines and Their Receptors: Drug Targets in Immunity and Inflammation. Annu Rev Pharmacol Toxicol 2008;48:171-197.
12. Gijsbers K, Gouwy M, Struyf S, Wuyts A, Proost P, Opdenakker G, Penninckx F, Ectors N, Geboes K, Van Damme J: GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res 2005;303:331-342.
13. Murphy PM: International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 2002;54:227-229.
14. Rabiet MJ, Huet E, Boulay F: The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 2007;89:1089-1106.
15. Boman HG: Antibacterial peptides: basic facts and emerging concepts. J Intern Med 2003;254:197-215.
16. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, Oppenheim JJ: Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-528.
17. Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J: The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human betadefensins. J Biol Chem 2002;277:37647-37654.
18. Schutyser E, Struyf S, Van Damme J: The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factors Rev 2003;14:409-426.
19. Hieshima K, Imai T, Opdendakker G, Van Damme J, Kusuda J, Tei H, Sakaki Y, Takatsuki K, Miura R, Yoshie O, Nomiyama H: Molecular cloning of a novel CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization to chromosome 2. J Biol Chem 1997;272:5846-5853.
20. Soruri A, Grigat J, Forssmann U, Rigegrt J, Zwirner J: beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 2007;37:2474-2486.
21. Starner TD, Barker CK, Jia HP, Kang Y, McCray PB Jr: CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 2003;29:627-633.
22. Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, Jenkins N, Copeland NG, Gilbert DJ, Nguyen N, Abrams J, Kershenovich D, Smith K, McClanahan T, Vicari AP, Zlotnik A: Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000;275:22313-22323.
23. Lazarus NH, Kunkel EJ, Johnston B, Wilson E, Youngman KR, Butcher EC: A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 2003;170:3799-3805.
24. Yount NY, Waring AJ, Gank KD, Welch WH, Kupferwasser D, Yeaman MR: Structural correlates of antimicrobial efficacy in IL-8 and related human kinocidins. Biochim Biophys Acta 2007;1768:598-608.
25. Björstad A, Fu H, Karlsson A, Dahlgren C, Bylund J: Interleukin-8-derived peptide has antibacterial activity. Antimicrob Agents Chemother 2005;49:3889-3895.
26. Richmond A, Thomas HG: Purification of melanoma growth stimulatory activity. J Cell Physiol 1986;129:375-384.
27. Becker S, Quay J, Koren HS, Haskill JS: Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am J Physiol 1994;266:278-286.
28. Wuyts A, Proost P, Lenaerts JP, Ben-Baruch A, Van Damme J, Wang JM: Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem 1998;255:67-73.
29. Linge HM, Collin M, Mörgelin M, Egesten A: The human CXC chemokine GCP-2/CXCL6 possesses antibacterial activity. Submitted for publication.
30. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM: Human Mig chemokine: biochemical and functional characterization. J Exp Med 1995;182:1301-1314.
31. Luster AD, Ravetch JV: Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 1987;166:1084-1097.
32. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K: Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998;187:2009-2021.
33. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-969.
34. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD: The T cell-specific CXC chemokines IP-10, Mig, and ITAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-3558.
35. Egesten A, Eliasson M, Johansson HM, Olin AI, Mögelin M, Mueller A, Pease JE, Frick IM, Björck L: The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 2007;195:684-693.
36. Tang YQ, Yeaman MR, Selsted ME: Antimicrobial peptides from human platelets. Infect Immun 2002;70:6524-6533.
37. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3:710-720.
38. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996;271:2935-2940.
39. Yang D, Chen Q, Chertov O, Oppenheim JJ: Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 2000;68:9-14.
40. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J: Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007;179:3958-3965.
41. Borregaard N, Cowland JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-3521.
42. Borregaard N, Sørensen OE, Theilgaard-Mönch K: Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007;28:340-345.
43. Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, Arfors KE, Flodgaard H, Lindbom L: Heparin-binding protein (HBP/ CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 2001;7:1123-1127.
44. Pereira HA, Shafer WM, Pohl J, Martin LE, Spitznagel JK: CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest 1990;85:1468-1476.
45. Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, Howard OM, Sayers TJ, Oppenheim JJ: Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 1997;186:739-747.
46. Odeberg H, Olsson I: Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein. Infect Immun 1976;14:1276-1283.
47. Sun R, Iribarren P, Zhang N, Zhou Y, Gong W, Cho EH, Lockett S, Chertov O, Bednar F, Rogers TJ, Oppenheim JJ, Wang JM: Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 2004;173:428-436.
48. Malm J, Sørensen O, Persson T, Frohm-Nilsson M, Johansson B, Bjartell A, Lilja H, Ståhle-Backdahl M, Borregaard N, Egesten A: The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun 2000;68:4297-4302.
49. Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Ståhle-Bäckdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999;67:2561-2566.
50. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
51. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melian A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL: An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998;282:121-125.
52. Clayberger C, Krensky AM: Granulysin. Curr Opin Immunol 2003;15:560-565.
53. Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM: Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005;174:5243-5248.
54. Linge HM, Collin M, Giwercman A, Malm J, Bjartell A, Egesten A: The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma. J Interferon Cytokine Res 2008;28:191-196.
55. Nordahl EA, Rydengård V, Nyberg P, Nitsche DP, Mörgelin M, Malmsten M, Björck L, Schmidtchen A: Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci USA 2004;101:16879-16884.
56. Pasupuleti M, Walse B, Nordahl EA, Mörgelin M, Malmsten M, Schmidtchen A: Preservation of antimicrobial properties of complement peptide C3a, from invertebrates to humans. J Biol Chem 2007;282:2520-2528.
57. Janeway CA Jr: The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11-16.
58. Matzinger P: The danger model: a renewed sense of self. Science 2002;296:301-305.
59. Oppenheim JJ, Yang D: Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005;17:359-365.
60. Yeaman MR, Yount NY: Unifying themes in host defence effector polypeptides. Nat Rev Microbiol 2007;5:727-740.
61. Qian YQ, Johanson K, McDevitt P: Nuclear magnetic resonance solution structure of truncated human GRO-beta [5-73] and its structural comparison with CXC-chemokine family members GROalpha and IL-8. J Mol Biol 1999;294:1065-1072.
62. Swaminathan GJ, Holloway DE, Colvin RA, Campanella GK, Papageorgiou AC, Luster AD, Acharya KR: Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine. Structure (Camb) 2003;11:521-532.
63. Booth V, Clark-Lewis I, Sykes BD: NMR structure of CXCR3 binding chemokine CXCL11 (ITAC). Protein Sci 2004;13:2022-2028.